[ET Net News Agency, 11 April 2025] HANSOH PHARMA (03692) rose 2.7% to HK$22.55.
It hits an intra-day high of HK$22.65, and an intra-day low of HK$21.8. The total shares
traded was 6.98 million, with a value of HK$155.23m. The active buy/sell ratio is 64:36,
with net buying turnover of HK$41.2m. CHINA INNOVATION MARKET SER accounts for greatest
net responsive buying turnover of HK$4.74m, with volume weighted average price of
HK$22.26. CITIGROUP GLOBAL accounts for greatest net responsive selling turnover of
HK$15.02m, with volume weighted average price of HK$22.286. The stock has risen a combined
9.2% over the past 4 consecutive trading days.
The Hang Seng Index now rose 424 points, or 2.1% to 21,106.

Basic Information
=================

----------------------------------
Nominal 22.550 % Chg +2.73%
High 22.650 Low 21.800
Shares Tr 6.98m Turnover 155.23m
10-D SMA 22.910 %H.V 71.172
20-D SMA 21.696 VWAP 22.243
50-D SMA 19.725 RSI14 57.781
----------------------------------
Status: Active buy/sell ratio is 64:36, with net buying turnover of HK$41.2m, rising a
combined 9.2% over the past 4 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 22.55 +2.73
SIHUAN PHARM (00460) 0.65 +6.56
GRAND PHARMA (00512) 5.92 +0.51
SINO BIOPHARM (01177) 3.56 +3.49
LIVZON PHARMA (01513) 25.85 -0.58
LUYE PHARMA (02186) 1.81 +1.69
FOSUN PHARMA (02196) 13.86 +1.76
SH PHARMA (02607) 10.70 +0.56
JACOBSON PHARMA (02633) 1.26 +5.88
CHINARES PHARMA (03320) 4.93 -0.40
-----------------------------------------------
(ed)